Allergan Foundation Research Grant
To support talented optometry and vision science faculty and researchers in innovative research in the area of glaucoma or the anterior segment, the American Optometric Foundation (AOF) is now accepting proposals for one research grant sponsored by The Allergan Foundation.
Award and Eligibility
The award is open to all faculty and researchers in optometry and vision science. Preference will be given to North American applicants. One, one-year award, of $60,000, plus a $750 travel grant for the Principal Investigator and up to three co-investigators on the project to attend the next annual meeting of the American Academy of Optometry (AAO).
The Principal Investigator must be a member of the American Academy of Optometry (AAO). It is also encouraged that the Co-Investigators be a member. To learn more, visit the AAO website: www.aaopt.org/becoming
All funds, as per policy of the American Academy of Optometry and the American Optometric Foundation, will be issued in U.S. currency to the primary institution of record.
Funds support research conducted for a period of one year in the area of glaucoma or the anterior segment. Recipient must submit a minimum 500-word report of his or her research findings to the AOF at the end of the award period in order to be eligible for subsequent awards sponsored by The Allergan Foundation.
Application and Review Procedures
Each proposal must be submitted electronically and contain the following components:
- Cover page: project title, institution and address, name (including degree(s)) and titles for Principal Investigator (and a maximum of three Co-Investigators) with contact information.
- Introduction: background and significance; specific aims; preliminary studies; and study design and methods. This section should total no more than 5 pages.
- References (maximum of 1 page)
- Budget and budget justification (maximum of 1 page) *NOTE: It is the policy of the Foundation not to cover indirect cost.
- Biographical sketch(es) of Principal Investigator and up to three Co-Investigators (maximum of 2 pages for each investigator) that must include:
- Full contact information
- Education/training; research and professional experience; honors and awards
- A copy of three key papers by the Principal Investigator that best represent his or her scientific publications (do not include abstracts, theses, or other applications). May include copies of papers in press.
- A signed Letter of Assurance (one page) by Dean or President indicating that the proposal has been reviewed and meets with the standards of the institution and, if warranted, observes all rules and regulations regarding compliance with research on human or animal subjects.
Proposals will be evaluated by a peer review committee established by the American Academy of Optometry's Research Committee and approved by the AOF Board of Directors. Preference will be given to North American applicants.
All proposals must be submitted by email to: AOF@aaoptom.org and contain in the subject title: Allergan Foundation Research + (Principal Investigator Last Name).
Applicants will receive a confirmation receipt by email from the AOF within 3 business days after submission. Files exceeding 10 MB must be broken into separate smaller units to allow passage through internet security measures.
The AOF is a non-profit organization and our policy is not to cover any indirect costs associated with the Allergan Foundation Research Program or any other of our programs.
The award recipient and an institution representative will be invited to attend the next AAO annual meeting in order to be recognized and participate at AOF events and the annual AOF Celebration Luncheon held on Saturday.
Any manuscript or publication material produced must acknowledge the American Optometric Foundation and The Allergan Foundation.
Recipients are encouraged to submit a manuscript to Optometry and Vision Science.
All award recipients by application and acceptance of an award agree to allow the AOF and/or the sponsor of the program to which they applied to publish their name, image, institution information, and any statement or quote provided by the recipient. These may appear in a variety of media formats that will announce and promote the program including, but not limited to, the AOF’s and/or sponsor’s annual report, website, annual meeting promotional materials.
For additional information contact:
Jennifer Rubin, Foundation Coordinator, at 321-319-4870 or AOF@aaoptom.org
American Optometric Foundation Announces 2016 Allergan Foundation Research Grant Winner
ORLANDO, FL (Nov 9, 2016) – The American Optometric Foundation (AOF), in partnership with the Allergan Foundation,is pleased to announce the 2016 recipient of the Allergan Research Grant. This highly competitive grant is awarded to a talented optometrist and/or vision scientist who is an Academy member and is currently undertaking cutting edge research in the area of either glaucoma or the anterior segment. This is the third year that the Allergan Foundation has sponsored this generous grant through AOF.
Congratulations to Steven Allen Burns, PhD, FARVO, FAAO, professor at Indiana University, who has been awarded a $60,000 grant for his project “High Resolution, Adaptive Optics Imaging of the Trabecular Meshwork in Vivo.”
“The American Optometric Foundation is pleased to partner with the Allergan Foundation to recognize individuals whose work will contribute to the future of optometric care.” We congratulate Dr. Burns on his award and on her cutting edge research that will eventually improve our patients’ eye health,” said AOF President David Kirschen, OD, PhD, FAAO
Dr. Burns will be honored for his achievement at the annual AOF Celebration Luncheon during Academy 2017 Chicago.
Past Program Recipients:
Nicole Carnt, PhD, BOptom, FAAO
Save Sight Institute, University of Sydney
Project: An investigation of the host immune reaction in response to corneal infection.
Nancy A. McNamara, OD, FAAO
University of California, Berkeley School of Optometry
Project: Defining the role of corneal epithelial progenitor cells in the pathogenesis of immune-mediated, aqueous-deficient dry eye disease.